Search results
Results from the WOW.Com Content Network
The WHO Model List of Essential Medicines for Children (aka Essential Medicines List for Children [1] or EMLc [1]), published by the World Health Organization (WHO), contains the medications considered to be most effective and safe in children up to twelve years of age to meet the most important needs in a health system.
The PUMA process was established to make it more profitable for pharmaceutical companies to market drugs for children. For this purpose, new data used for PUMA approved drugs are protected for 10 years, and the applications are partially exempt from fees. [1] In September 2011, the first drug was approved under this process.
Performance-enhancing substances (PESs), also known as performance-enhancing drugs (PEDs), [1] are substances that are used to improve any form of activity performance in humans. Many substances, such as anabolic steroids , can be used to improve athletic performance and build muscle, which in most cases is considered cheating by organized ...
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
Pediatric cancer doctors are sounding the alarm about a growing shortage of chemotherapy drugs for children. Pediatric cancer drugs in shortage as drug supply crisis drags on Skip to main content
The first list was published in 1977 and included 208 medications. [8] [2] [9] The WHO updates the list every two years. [10] There are 306 medications in the 14th list in 2005, [11] 410 in the 19th list in 2015, [10] 433 in the 20th list in 2017, [12] [13] 460 in the 21st list in 2019, [14] [15] [16] and 479 in the 22nd list in 2021.
A new database of NFL performance-enhancing drug suspensions shows persistent issues in a sport that rewards strength, size and speed. NFL players suspended for PED violations at least 258 times ...
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.